% alzhub.org library filter
% Source: https://alzhub.org/research?category=mci&atag=csf
% 58 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{hansson2018-29499171,
  author  = {Hansson, O. and Seibyl, J. and Stomrud, E. and Zetterberg, H. and Trojanowski, J. Q. and Bittner, T. and Lifke, V. and Corradini, V. and others},
  title   = {{CSF biomarkers of Alzheimer's disease concord with amyloid-β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2018},
  doi     = {10.1016/j.jalz.2018.01.010},
  pmid    = {29499171},
  url     = {https://doi.org/10.1016/j.jalz.2018.01.010}
}

@article{ayton2015-25988319,
  author  = {Ayton, S. and Faux, N. G. and Bush, A. I. and {Alzheimer's Disease Neuroimaging Initiative}},
  title   = {{Ferritin levels in the cerebrospinal fluid predict Alzheimer's disease outcomes and are regulated by APOE}},
  journal = {Nature communications},
  year    = {2015},
  doi     = {10.1038/ncomms7760},
  pmid    = {25988319},
  url     = {https://doi.org/10.1038/ncomms7760}
}

@article{petersen2016-26595683,
  author  = {Petersen, R. C. and Wiste, H. J. and Weigand, S. D. and Rocca, W. A. and Roberts, R. O. and Mielke, M. M. and Lowe, V. J. and Knopman, D. S. and others},
  title   = {{Association of Elevated Amyloid Levels With Cognition and Biomarkers in Cognitively Normal People From the Community}},
  journal = {JAMA neurology},
  year    = {2016},
  doi     = {10.1001/jamaneurol.2015.3098},
  pmid    = {26595683},
  url     = {https://doi.org/10.1001/jamaneurol.2015.3098}
}

@article{toledo2011-21805181,
  author  = {Toledo, J. B. and Vanderstichele, H. and Figurski, M. and Aisen, P. S. and Petersen, R. C. and Weiner, M. W. and Jack, C. R. and Jagust, W. and others},
  title   = {{Factors affecting Aβ plasma levels and their utility as biomarkers in ADNI}},
  journal = {Acta neuropathologica},
  year    = {2011},
  doi     = {10.1007/s00401-011-0861-8},
  pmid    = {21805181},
  url     = {https://doi.org/10.1007/s00401-011-0861-8}
}

@article{kester2015-26366630,
  author  = {Kester, M. I. and Teunissen, C. E. and Crimmins, D. L. and Herries, E. M. and Ladenson, J. H. and Scheltens, P. and van der Flier, W. M. and Morris, J. C. and others},
  title   = {{Neurogranin as a Cerebrospinal Fluid Biomarker for Synaptic Loss in Symptomatic Alzheimer Disease}},
  journal = {JAMA neurology},
  year    = {2015},
  doi     = {10.1001/jamaneurol.2015.1867},
  pmid    = {26366630},
  url     = {https://doi.org/10.1001/jamaneurol.2015.1867}
}

@article{thambisetty2010-20603455,
  author  = {Thambisetty, M. and Simmons, A. and Velayudhan, L. and Hye, A. and Campbell, J. and Zhang, Y. and Wahlund, L. O. and Westman, E. and others},
  title   = {{Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease}},
  journal = {Archives of general psychiatry},
  year    = {2010},
  doi     = {10.1001/archgenpsychiatry.2010.78},
  pmid    = {20603455},
  url     = {https://doi.org/10.1001/archgenpsychiatry.2010.78}
}

@article{bubu2019-30794315,
  author  = {Bubu, O. M. and Pirraglia, E. and Andrade, A. G. and Sharma, R. A. and Gimenez-Badia, S. and Umasabor-Bubu, O. Q. and Hogan, M. M. and Shim, A. M. and others},
  title   = {{Obstructive sleep apnea and longitudinal Alzheimer's disease biomarker changes}},
  journal = {Sleep},
  year    = {2019},
  doi     = {10.1093/sleep/zsz048},
  pmid    = {30794315},
  url     = {https://doi.org/10.1093/sleep/zsz048}
}

@article{meghdadi2021-33544703,
  author  = {Meghdadi, A. H. and Stevanović Karić, M. and McConnell, M. and Rupp, G. and Richard, C. and Hamilton, J. and Salat, D. and Berka, C.},
  title   = {{Resting state EEG biomarkers of cognitive decline associated with Alzheimer's disease and mild cognitive impairment}},
  journal = {PloS one},
  year    = {2021},
  doi     = {10.1371/journal.pone.0244180},
  pmid    = {33544703},
  url     = {https://doi.org/10.1371/journal.pone.0244180}
}

@article{qin2017-27113997,
  author  = {Qin, X. Y. and Cao, C. and Cawley, N. X. and Liu, T. T. and Yuan, J. and Loh, Y. P. and Cheng, Y.},
  title   = {{Decreased peripheral brain-derived neurotrophic factor levels in Alzheimer's disease: a meta-analysis study (N=7277)}},
  journal = {Molecular psychiatry},
  year    = {2017},
  doi     = {10.1038/mp.2016.62},
  pmid    = {27113997},
  url     = {https://doi.org/10.1038/mp.2016.62}
}

@article{morgan2019-31047856,
  author  = {Morgan, A. R. and Touchard, S. and Leckey, C. and O'Hagan, C. and Nevado-Holgado, A. J. and {NIMA Consortium} and Barkhof, F. and Bertram, L. and others},
  title   = {{Inflammatory biomarkers in Alzheimer's disease plasma}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2019},
  doi     = {10.1016/j.jalz.2019.03.007},
  pmid    = {31047856},
  url     = {https://doi.org/10.1016/j.jalz.2019.03.007}
}

@article{diniz2008-17886169,
  author  = {Diniz, B. S. and Pinto Júnior, J. A. and Forlenza, O. V.},
  title   = {{Do CSF total tau, phosphorylated tau, and beta-amyloid 42 help to predict progression of mild cognitive impairment to Alzheimer's disease? A systematic review and meta-analysis of the literature}},
  journal = {The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry},
  year    = {2008},
  doi     = {10.1080/15622970701535502},
  pmid    = {17886169},
  url     = {https://doi.org/10.1080/15622970701535502}
}

@article{brosseron2014-24567119,
  author  = {Brosseron, F. and Krauthausen, M. and Kummer, M. and Heneka, M. T.},
  title   = {{Body fluid cytokine levels in mild cognitive impairment and Alzheimer's disease: a comparative overview}},
  journal = {Molecular neurobiology},
  year    = {2014},
  doi     = {10.1007/s12035-014-8657-1},
  pmid    = {24567119},
  url     = {https://doi.org/10.1007/s12035-014-8657-1}
}

@article{tripanpitak2026-41636372,
  author  = {Tripanpitak, Kornkanok and Wolf, Alexandra and Kapitonova, Maryna and Umeda, Satoshi and Ball, Tonio and Otake, Mihoko},
  title   = {{Biomarkers for Alzheimer's disease and mild cognitive impairment: Recent advances in task-based EEG}},
  journal = {Journal of Alzheimer s Disease},
  year    = {2026},
  doi     = {10.1177/13872877251413700},
  pmid    = {41636372},
  url     = {https://doi.org/10.1177/13872877251413700}
}

@article{hye2014-25012867,
  author  = {Hye, A. and Riddoch-Contreras, J. and Baird, A. L. and Ashton, N. J. and Bazenet, C. and Leung, R. and Westman, E. and others},
  title   = {{Plasma proteins predict conversion to dementia from prodromal disease}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2014},
  doi     = {10.1016/j.jalz.2014.05.1749},
  pmid    = {25012867},
  url     = {https://doi.org/10.1016/j.jalz.2014.05.1749}
}

@article{perrin2011-21264269,
  author  = {Perrin, R. J. and Craig-Schapiro, R. and Malone, J. P. and Shah, A. R. and Gilmore, P. and Davis, A. E. and Roe, C. M. and Peskind, E. R. and others},
  title   = {{Identification and validation of novel cerebrospinal fluid biomarkers for staging early Alzheimer's disease}},
  journal = {PloS one},
  year    = {2011},
  doi     = {10.1371/journal.pone.0016032},
  pmid    = {21264269},
  url     = {https://doi.org/10.1371/journal.pone.0016032}
}

@article{riemenschneider2002-12433260,
  author  = {Riemenschneider, M. and Lautenschlager, N. and Wagenpfeil, S. and Diehl, J. and Drzezga, A. and Kurz, A.},
  title   = {{Cerebrospinal fluid tau and beta-amyloid 42 proteins identify Alzheimer disease in subjects with mild cognitive impairment}},
  journal = {Archives of neurology},
  year    = {2002},
  doi     = {10.1001/archneur.59.11.1729},
  pmid    = {12433260},
  url     = {https://doi.org/10.1001/archneur.59.11.1729}
}

@article{kester2015-26383836,
  author  = {Kester, M. I. and Teunissen, C. E. and Sutphen, C. and Herries, E. M. and Ladenson, J. H. and Xiong, C. and Scheltens, P. and van der Flier, W. M. and others},
  title   = {{Cerebrospinal fluid VILIP-1 and YKL-40, candidate biomarkers to diagnose, predict and monitor Alzheimer's disease in a memory clinic cohort}},
  journal = {Alzheimer's research \& therapy},
  year    = {2015},
  doi     = {10.1186/s13195-015-0142-1},
  pmid    = {26383836},
  url     = {https://doi.org/10.1186/s13195-015-0142-1}
}

@article{rosen2013-23800368,
  author  = {Rosén, C. and Hansson, O. and Blennow, K. and Zetterberg, H.},
  title   = {{Fluid biomarkers in Alzheimer's disease - current concepts}},
  journal = {Molecular neurodegeneration},
  year    = {2013},
  doi     = {10.1186/1750-1326-8-20},
  pmid    = {23800368},
  url     = {https://doi.org/10.1186/1750-1326-8-20}
}

@article{donaghy2025-40156325,
  author  = {Donaghy, Paul C. and Hasoon, Jahfer and Hamilton, Calum Alexander and Ciafone, Joanna and Durcan, Rory and Barnett, Nicola A. and Olsen, Kirsty and Lawley, Sarah and others},
  title   = {{Plasma Biomarkers and Disease Prognosis in Mild Cognitive Impairment with Lewy Bodies}},
  journal = {Movement Disorders},
  year    = {2025},
  doi     = {10.1002/mds.30181},
  pmid    = {40156325},
  url     = {https://doi.org/10.1002/mds.30181}
}

@article{trushina2013-23700429,
  author  = {Trushina, E. and Dutta, T. and Persson, X. M. and Mielke, M. M. and Petersen, R. C.},
  title   = {{Identification of altered metabolic pathways in plasma and CSF in mild cognitive impairment and Alzheimer's disease using metabolomics}},
  journal = {PloS one},
  year    = {2013},
  doi     = {10.1371/journal.pone.0063644},
  pmid    = {23700429},
  url     = {https://doi.org/10.1371/journal.pone.0063644}
}

@article{tadayon2020-32107064,
  author  = {Tadayon, E. and Pascual-Leone, A. and Press, D. and Santarnecchi, E. and {Alzheimer's Disease Neuroimaging Initiative}},
  title   = {{Choroid plexus volume is associated with levels of CSF proteins: relevance for Alzheimer's and Parkinson's disease}},
  journal = {Neurobiology of aging},
  year    = {2020},
  doi     = {10.1016/j.neurobiolaging.2020.01.005},
  pmid    = {32107064},
  url     = {https://doi.org/10.1016/j.neurobiolaging.2020.01.005}
}

@article{muraoka2020-32854315,
  author  = {Muraoka, S. and Jedrychowski, M. P. and Yanamandra, K. and Ikezu, S. and Gygi, S. P. and Ikezu, T.},
  title   = {{Proteomic Profiling of Extracellular Vesicles Derived from Cerebrospinal Fluid of Alzheimer's Disease Patients: A Pilot Study}},
  journal = {Cells},
  year    = {2020},
  doi     = {10.3390/cells9091959},
  pmid    = {32854315},
  url     = {https://doi.org/10.3390/cells9091959}
}

@article{han2026-41553038,
  author  = {Han, Xue and Zhu, Shouqiang and Zhang, Heng and Xia, Tianjiao and Gu, Xiaoping},
  title   = {{Multiplex Cerebrospinal Fluid Proteomics Identifies Biomarkers Predicting Neuropsychiatric Symptom Progression in Mild Cognitive Impairment and Alzheimer's Disease}},
  journal = {The FASEB Journal},
  year    = {2026},
  doi     = {10.1096/fj.202504014r},
  pmid    = {41553038},
  url     = {https://doi.org/10.1096/fj.202504014r}
}

@article{vanharten2013-23232269,
  author  = {van Harten, A. C. and Visser, P. J. and Pijnenburg, Y. A. and Teunissen, C. E. and Blankenstein, M. A. and Scheltens, P. and van der Flier, W. M.},
  title   = {{Cerebrospinal fluid Aβ42 is the best predictor of clinical progression in patients with subjective complaints}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2013},
  doi     = {10.1016/j.jalz.2012.08.004},
  pmid    = {23232269},
  url     = {https://doi.org/10.1016/j.jalz.2012.08.004}
}

@article{galasko2019-31853477,
  author  = {Galasko, D. and Xiao, M. and Xu, D. and Smirnov, D. and Salmon, D. P. and Dewit, N. and Vanbrabant, J. and Jacobs, D. and others},
  title   = {{Synaptic biomarkers in CSF aid in diagnosis, correlate with cognition and predict progression in MCI and Alzheimer's disease}},
  journal = {Alzheimer's \& dementia (New York, N. Y.)},
  year    = {2019},
  doi     = {10.1016/j.trci.2019.11.002},
  pmid    = {31853477},
  url     = {https://doi.org/10.1016/j.trci.2019.11.002}
}

@article{valletta2025-41276530,
  author  = {Valletta, Martina and Vetrano, Davide Liborio and Gregorio, Caterina and Rizzuto, Debora and Winblad, Bengt G. and Canevelli, Marco and Andersson, Sarah Wamala and Dale, Matilda and others},
  title   = {{Blood biomarkers of Alzheimer’s disease and progression across different stages of cognitive decline in the community}},
  journal = {Nature Communications},
  year    = {2025},
  doi     = {10.1038/s41467-025-66728-2},
  pmid    = {41276530},
  url     = {https://doi.org/10.1038/s41467-025-66728-2}
}

@article{andreasen1999-10505638,
  author  = {Andreasen, N. and Minthon, L. and Vanmechelen, E. and Vanderstichele, H. and Davidsson, P. and Winblad, B. and Blennow, K.},
  title   = {{Cerebrospinal fluid tau and Abeta42 as predictors of development of Alzheimer's disease in patients with mild cognitive impairment}},
  journal = {Neuroscience letters},
  year    = {1999},
  doi     = {10.1016/s0304-3940(99)00617-5},
  pmid    = {10505638},
  url     = {https://doi.org/10.1016/s0304-3940(99)00617-5}
}

@article{herukka2017-28341066,
  author  = {Herukka, S. K. and Simonsen, A. H. and Andreasen, N. and Baldeiras, I. and Bjerke, M. and Blennow, K. and Engelborghs, S. and Frisoni, G. B. and others},
  title   = {{Recommendations for cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic evaluation of mild cognitive impairment}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2017},
  doi     = {10.1016/j.jalz.2016.09.009},
  pmid    = {28341066},
  url     = {https://doi.org/10.1016/j.jalz.2016.09.009}
}

@article{lee2026-42159446,
  author  = {Lee, Woong Jin and Cho, Kyoungjoo and Kim, Gyung Whan},
  title   = {{Integrated amyloid, neurodegeneration, and vascular biomarkers estimate the risk of dementia progression in mild cognitive impairment}},
  journal = {Journal of Alzheimer s Disease},
  year    = {2026},
  doi     = {10.1177/13872877261445623},
  pmid    = {42159446},
  url     = {https://doi.org/10.1177/13872877261445623}
}

@article{marksteiner2018-29249916,
  author  = {Marksteiner, J. and Blasko, I. and Kemmler, G. and Koal, T. and Humpel, C.},
  title   = {{Bile acid quantification of 20 plasma metabolites identifies lithocholic acid as a putative biomarker in Alzheimer's disease}},
  journal = {Metabolomics : Official journal of the Metabolomic Society},
  year    = {2018},
  doi     = {10.1007/s11306-017-1297-5},
  pmid    = {29249916},
  url     = {https://doi.org/10.1007/s11306-017-1297-5}
}

@article{da2014-24371799,
  author  = {Da, X. and Toledo, J. B. and Zee, J. and Wolk, D. A. and Xie, S. X. and Ou, Y. and Shacklett, A. and Parmpi, P. and others},
  title   = {{Integration and relative value of biomarkers for prediction of MCI to AD progression: spatial patterns of brain atrophy, cognitive scores, APOE genotype and CSF biomarkers}},
  journal = {NeuroImage. Clinical},
  year    = {2014},
  doi     = {10.1016/j.nicl.2013.11.010},
  pmid    = {24371799},
  url     = {https://doi.org/10.1016/j.nicl.2013.11.010}
}

@article{rodriguezantiguedad2025-40501082,
  author  = {Rodriguez‐Antiguedad, Jon and Puig‐Davi, Arnau and Ruíz‐Barrio, Iñigo and Pagonabarraga, Javier and Vázquez‐Oliver, Anna and Horta‐Barba, Andrea and Kulisevsky, Jaime and Martínez‐Horta, Saül},
  title   = {{CSF Biomarker‐Based Cognitive Trajectories in Parkinson's Disease‐Subjective Cognitive Decline}},
  journal = {Annals of Clinical and Translational Neurology},
  year    = {2025},
  doi     = {10.1002/acn3.70075},
  pmid    = {40501082},
  url     = {https://doi.org/10.1002/acn3.70075}
}

@article{peng2005-15935057,
  author  = {Peng, S. and Wuu, J. and Mufson, E. J. and Fahnestock, M.},
  title   = {{Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer's disease}},
  journal = {Journal of neurochemistry},
  year    = {2005},
  doi     = {10.1111/j.1471-4159.2005.03135.x},
  pmid    = {15935057},
  url     = {https://doi.org/10.1111/j.1471-4159.2005.03135.x}
}

@article{peng2004-15217092,
  author  = {Peng, S. and Wuu, J. and Mufson, E. J. and Fahnestock, M.},
  title   = {{Increased proNGF levels in subjects with mild cognitive impairment and mild Alzheimer disease}},
  journal = {Journal of neuropathology and experimental neurology},
  year    = {2004},
  doi     = {10.1093/jnen/63.6.641},
  pmid    = {15217092},
  url     = {https://doi.org/10.1093/jnen/63.6.641}
}

@article{perezgrijalba2019-30569084,
  author  = {Pérez-Grijalba, V. and Romero, J. and Pesini, P. and Sarasa, L. and Monleón, I. and San-José, I. and Arbizu, J. and Martínez-Lage, P. and others},
  title   = {{Plasma Aβ42/40 Ratio Detects Early Stages of Alzheimer's Disease and Correlates with CSF and Neuroimaging Biomarkers in the AB255 Study}},
  journal = {The journal of prevention of Alzheimer's disease},
  year    = {2019},
  doi     = {10.14283/jpad.2018.41},
  pmid    = {30569084},
  url     = {https://doi.org/10.14283/jpad.2018.41}
}

@article{ryczek2025-39789939,
  author  = {Ryczek, Cameron A. and Rivas, Rhiannon and Hemphill, Lea and Zanotelli, Zackary and Renteria, Nicholas and Dashtipour, Khashayar and Jones, Jacob D.},
  title   = {{Association of Favorable Cerebrospinal Fluid Markers With Reversion of Mild Cognitive Impairment Due to Parkinson’s Disease}},
  journal = {Journal of Neuropsychiatry},
  year    = {2025},
  doi     = {10.1176/appi.neuropsych.20240099},
  pmid    = {39789939},
  url     = {https://doi.org/10.1176/appi.neuropsych.20240099}
}

@article{mandal2015-26003861,
  author  = {Mandal, P. K. and Saharan, S. and Tripathi, M. and Murari, G.},
  title   = {{Brain glutathione levels--a novel biomarker for mild cognitive impairment and Alzheimer's disease}},
  journal = {Biological psychiatry},
  year    = {2015},
  doi     = {10.1016/j.biopsych.2015.04.005},
  pmid    = {26003861},
  url     = {https://doi.org/10.1016/j.biopsych.2015.04.005}
}

@article{padurariu2010-19914330,
  author  = {Padurariu, M. and Ciobica, A. and Hritcu, L. and Stoica, B. and Bild, W. and Stefanescu, C.},
  title   = {{Changes of some oxidative stress markers in the serum of patients with mild cognitive impairment and Alzheimer's disease}},
  journal = {Neuroscience letters},
  year    = {2010},
  doi     = {10.1016/j.neulet.2009.11.033},
  pmid    = {19914330},
  url     = {https://doi.org/10.1016/j.neulet.2009.11.033}
}

@article{papassotiropoulos2002-11755458,
  author  = {Papassotiropoulos, A. and Lütjohann, D. and Bagli, M. and Locatelli, S. and Jessen, F. and Buschfort, R. and Ptok, U. and Björkhem, I. and others},
  title   = {{24S-hydroxycholesterol in cerebrospinal fluid is elevated in early stages of dementia}},
  journal = {Journal of psychiatric research},
  year    = {2002},
  doi     = {10.1016/s0022-3956(01)00050-4},
  pmid    = {11755458},
  url     = {https://doi.org/10.1016/s0022-3956(01)00050-4}
}

@article{teixeira2013-23055000,
  author  = {Teixeira, A. L. and Diniz, B. S. and Campos, A. C. and Miranda, A. S. and Rocha, N. P. and Talib, L. L. and Gattaz, W. F. and Forlenza, O. V.},
  title   = {{Decreased levels of circulating adiponectin in mild cognitive impairment and Alzheimer's disease}},
  journal = {Neuromolecular medicine},
  year    = {2013},
  doi     = {10.1007/s12017-012-8201-2},
  pmid    = {23055000},
  url     = {https://doi.org/10.1007/s12017-012-8201-2}
}

@article{popp2015-25435336,
  author  = {Popp, J. and Wolfsgruber, S. and Heuser, I. and Peters, O. and Hüll, M. and Schröder, J. and Möller, H. J. and Lewczuk, P. and others},
  title   = {{Cerebrospinal fluid cortisol and clinical disease progression in MCI and dementia of Alzheimer's type}},
  journal = {Neurobiology of aging},
  year    = {2015},
  doi     = {10.1016/j.neurobiolaging.2014.10.031},
  pmid    = {25435336},
  url     = {https://doi.org/10.1016/j.neurobiolaging.2014.10.031}
}

@article{dickerson2013-24130528,
  author  = {Dickerson, B. C. and Wolk, D. A. and {Alzheimer's Disease Neuroimaging Initiative}},
  title   = {{Biomarker-based prediction of progression in MCI: Comparison of AD signature and hippocampal volume with spinal fluid amyloid-β and tau}},
  journal = {Frontiers in aging neuroscience},
  year    = {2013},
  doi     = {10.3389/fnagi.2013.00055},
  pmid    = {24130528},
  url     = {https://doi.org/10.3389/fnagi.2013.00055}
}

@article{jensen1999-10211475,
  author  = {Jensen, M. and Schröder, J. and Blomberg, M. and Engvall, B. and Pantel, J. and Ida, N. and Basun, H. and Wahlund, L. O. and others},
  title   = {{Cerebrospinal fluid A beta42 is increased early in sporadic Alzheimer's disease and declines with disease progression}},
  journal = {Annals of neurology},
  year    = {1999},
  doi     = {10.1002/1531-8249(199904)45:4<504::aid-ana12>3.0.co;2-9},
  pmid    = {10211475},
  url     = {https://doi.org/10.1002/1531-8249(199904)45:4<504::aid-ana12>3.0.co;2-9}
}

@article{italiani2018-30541566,
  author  = {Italiani, P. and Puxeddu, I. and Napoletano, S. and Scala, E. and Melillo, D. and Manocchio, S. and Angiolillo, A. and Migliorini, P. and others},
  title   = {{Circulating levels of IL-1 family cytokines and receptors in Alzheimer's disease: new markers of disease progression?}},
  journal = {Journal of neuroinflammation},
  year    = {2018},
  doi     = {10.1186/s12974-018-1376-1},
  pmid    = {30541566},
  url     = {https://doi.org/10.1186/s12974-018-1376-1}
}

@article{yuan2025-40336944,
  author  = {Yuan, Yue and Zhao, Yang},
  title   = {{The role of quantitative EEG biomarkers in Alzheimer’s disease and mild cognitive impairment: applications and insights}},
  journal = {Frontiers in Aging Neuroscience},
  year    = {2025},
  doi     = {10.3389/fnagi.2025.1522552},
  pmid    = {40336944},
  url     = {https://doi.org/10.3389/fnagi.2025.1522552}
}

@article{souzatalarico2025-40606518,
  author  = {Souza‐Talarico, Juliana Nery and Perkhounkova, Yelena and Hein, Maria and Lee, Jihye and Hefti, Marco M. and Sindi, Shireen},
  title   = {{Allostatic load dynamics, Alzheimer's disease biomarkers, and progression in individuals with mild cognitive impairment: findings from the Alzheimer's Disease Neuroimaging Initiative}},
  journal = {Alzheimer s \& Dementia Diagnosis Assessment \& Disease Monitoring},
  year    = {2025},
  doi     = {10.1002/dad2.70140},
  pmid    = {40606518},
  url     = {https://doi.org/10.1002/dad2.70140}
}

@article{hazan2026-42081782,
  author  = {Hazan, Jemma and Liu, Kathy Y and Isaacs, Jeremy Darryl and Fox, Nick C. and Howard, Robert},
  title   = {{What Does a Positive Alzheimer Disease Blood-Based Biomarker Result Mean in People With Mild Cognitive Impairment?}},
  journal = {Neurology},
  year    = {2026},
  doi     = {10.1212/wnl.0000000000214953},
  pmid    = {42081782},
  url     = {https://doi.org/10.1212/wnl.0000000000214953}
}

@article{hays2016-26898552,
  author  = {Hays, C. C. and Zlatar, Z. Z. and Wierenga, C. E.},
  title   = {{The Utility of Cerebral Blood Flow as a Biomarker of Preclinical Alzheimer's Disease}},
  journal = {Cellular and molecular neurobiology},
  year    = {2016},
  doi     = {10.1007/s10571-015-0261-z},
  pmid    = {26898552},
  url     = {https://doi.org/10.1007/s10571-015-0261-z}
}

@article{chiu2025-39758054,
  author  = {Chiu, Yen‐Ling and Yan, Sui‐Hing and Fan, Yang‐Teng and Chang, Chiung‐Fang and Hung, Ruo‐Wei and Liu, Yi‐Chien and Yang, TienYu Owen and Chuang, Yi‐Fang},
  title   = {{Aβ‐reactive T cell polyfunctionality response as a new biomarker for mild cognitive impairment}},
  journal = {Alzheimer s \& Dementia Diagnosis Assessment \& Disease Monitoring},
  year    = {2025},
  doi     = {10.1002/dad2.70042},
  pmid    = {39758054},
  url     = {https://doi.org/10.1002/dad2.70042}
}

@article{spellman2015-25676562,
  author  = {Spellman, D. S. and Wildsmith, K. R. and Honigberg, L. A. and Tuefferd, M. and Baker, D. and Raghavan, N. and Nairn, A. C. and Croteau, P. and others},
  title   = {{Development and evaluation of a multiplexed mass spectrometry based assay for measuring candidate peptide biomarkers in Alzheimer's Disease Neuroimaging Initiative (ADNI) CSF}},
  journal = {Proteomics. Clinical applications},
  year    = {2015},
  doi     = {10.1002/prca.201400178},
  pmid    = {25676562},
  url     = {https://doi.org/10.1002/prca.201400178}
}

@article{bradleywhitman2015-25895140,
  author  = {Bradley-Whitman, M. A. and Lovell, M. A.},
  title   = {{Biomarkers of lipid peroxidation in Alzheimer disease (AD): an update}},
  journal = {Archives of toxicology},
  year    = {2015},
  doi     = {10.1007/s00204-015-1517-6},
  pmid    = {25895140},
  url     = {https://doi.org/10.1007/s00204-015-1517-6}
}

@article{guerreiro2007-17934323,
  author  = {Guerreiro, R. J. and Santana, I. and Brás, J. M. and Santiago, B. and Paiva, A. and Oliveira, C.},
  title   = {{Peripheral inflammatory cytokines as biomarkers in Alzheimer's disease and mild cognitive impairment}},
  journal = {Neuro-degenerative diseases},
  year    = {2007},
  doi     = {10.1159/000107700},
  pmid    = {17934323},
  url     = {https://doi.org/10.1159/000107700}
}

@article{mai2025-41453218,
  author  = {Mai, Yingren and Cao, Zhiyu and Yu, Qun and Liu, Jun},
  title   = {{Metabolomics and lipidomics study on serum metabolite signatures in Alzheimer's disease and mild cognitive impairment}},
  journal = {Alzheimer s \& Dementia},
  year    = {2025},
  doi     = {10.1002/alz70856_104134},
  pmid    = {41453218},
  url     = {https://doi.org/10.1002/alz70856_104134}
}

@article{marksteiner2011-19395124,
  author  = {Marksteiner, J. and Kemmler, G. and Weiss, E. M. and Knaus, G. and Ullrich, C. and Mechtcheriakov, S. and Oberbauer, H. and Auffinger, S. and others},
  title   = {{Five out of 16 plasma signaling proteins are enhanced in plasma of patients with mild cognitive impairment and Alzheimer's disease}},
  journal = {Neurobiology of aging},
  year    = {2011},
  doi     = {10.1016/j.neurobiolaging.2009.03.011},
  pmid    = {19395124},
  url     = {https://doi.org/10.1016/j.neurobiolaging.2009.03.011}
}

@article{pradhan2026-41949144,
  author  = {Pradhan, Rashmita and Kumari, Sakshi and Singh, Abhinay Kumar and Rao, Abhijith R. and Yadav, Yudhishthir and Upadhyay, Ashish Datt and Mehta, Pramod Kumar and Dey, Aparajit B. and others},
  title   = {{Blood level of β-amyloid, Tau, and p-Tau in mild cognitive impairment and Alzheimer disease: A follow up study}},
  journal = {The Indian Journal of Medical Research},
  year    = {2026},
  doi     = {10.25259/ijmr_2164_2025},
  pmid    = {41949144},
  url     = {https://doi.org/10.25259/ijmr_2164_2025}
}

@article{leelahavarong2026-41928210,
  author  = {Leelahavarong, Pattara and Prawjaeng, Juthamas and Angkab, Pakkanan and Wongkom, Natthamon and Scheltens, Philip and Srinonprasert, Varalak and Senanarong, Vorapun},
  title   = {{Cost-utility analysis of cerebrospinal fluid versus blood biomarkers for early detection of Alzheimer’s disease and mild cognitive impairment in Thailand: a modeling study}},
  journal = {BMC Health Services Research},
  year    = {2026},
  doi     = {10.1186/s12913-026-14405-5},
  pmid    = {41928210},
  url     = {https://doi.org/10.1186/s12913-026-14405-5}
}

@article{altntop2025-40859599,
  author  = {Altıntop, Sabri Engin and Yurt, Emine Feyza and Ayçiçek, Gözde Şengül and Neşeli̇oğlu, Salim and Erel, Özcan and Doğu, Burcu Balam and Cankurtaran, Mustafa and Halil, Meltem Gulhan},
  title   = {{Evaluation of oxidative stress biomarkers in mild cognitive impairment and Alzheimer’s disease: targeting dynamic thiol–disulfide homeostasis and ischemia-modified albumin}},
  journal = {Neurological Research},
  year    = {2025},
  doi     = {10.1080/01616412.2025.2551865},
  pmid    = {40859599},
  url     = {https://doi.org/10.1080/01616412.2025.2551865}
}

@article{zhang2025-40576449,
  author  = {Zhang, Quanjun and Yu, Lan-ke and Zhang, Xin-yuan and Wu, You and Zhang, Heng and Wu, Jia-lin and Yao, Zhaohui and {Alzheimer's Disease Neuroimaging Initiative}},
  title   = {{LCN2 of cerebrospinal fluid: A potential biomarker for diagnosis and disease progression in Alzheimer's disease}},
  journal = {Journal of Alzheimer s Disease},
  year    = {2025},
  doi     = {10.1177/13872877251352411},
  pmid    = {40576449},
  url     = {https://doi.org/10.1177/13872877251352411}
}